The transformative role of CDMOs in biopharmaceutical product development

The fast-moving pace of the biopharmaceutical sector and the diversity of potential therapeutic targets are putting the industry’s resources under ever-growing pressure. Each new cell line or manufacturing technology requires dedicated time, space and staff – not to mention in-house…